Thyroid dysfunction in hodgkin's disease

• Published in: Cancer Vol. 63; no. 2; pp. 335 - 339
• Main Authors: Pasqualini, T., Iorcansky, S., Gruñeiro, L., Diez, B., Pavlovsky, S., Sackmann‐Muriel, F., Rivarola, M. A.
• Format: Journal Article
• Language: English
• Published: New York Wiley Subscription Services, Inc., A Wiley Company 15.01.1989; Wiley-Liss
• Subjects: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Biological and medical sciences; Bleomycin - administration & dosage; Child; Combined Modality Therapy; Cyclophosphamide - administration & dosage; Doxorubicin - administration & dosage; Female; Hematologic and hematopoietic diseases; Hodgkin Disease - complications; Hodgkin Disease - therapy; Humans; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Male; Medical sciences; Prednisone - administration & dosage; Procarbazine - administration & dosage; Thyroid Hormones - blood; Thyroiditis - etiology; Thyroiditis - immunology; Vinblastine - administration & dosage; Antineoplastic agent; Human; Iatrogenic; Thyroid diseases; Hodgkin disease; Autoimmune disease; Hemopathy; Thyroid gland; Radiotherapy; Chemotherapy; Complication; Neck; Hormonal investigation

Radiotherapy to the neck and/or polychemotherapy late effects on the thyroid were investigated in 51 patients (34 males and 17 females) with Hodgkin's disease. Except for two untreated, recently diagnosed patients, all were studied after 1 to 105 months (median, 27.5 months) of completion of po...